Meiji Seika Pharma：Meiji Seika ファルマ株式会社 明治グループの薬品会社
Meiji Seika ファルマ株式会社 明治グループの薬品会社
Pharmaceuticals
https://www.meiji.com
Beginning with the production of penicillin in 1946, Meiji Seika Pharma has established itself as a leader in the manufacture and sale of antibacterial drugs.
Pipeline
https://www.meiji.com
Meiji Seika Pharma Co., Ltd. Based in Japan, we are a leading developer and manufacturer of antibacterial drugs, vaccines and biotech solutions, with a ...
Meiji Seika Pharma 目標2026年營收達到2740億日圓
https://tpatw.org.tw
根據公司的預測，2026年營收將達到2,740億日元（約新台幣564億元），相較於2023年增加590億日元（約新台幣122億元），營業利潤將達到400億日元（約新台幣83億元）， ...
Meiji Seika Pharma
https://en.wikipedia.org
It markets treatments for depression, obsessive-compulsive disorder, vaccines and allergy drugs. Meiji Pharma is doing research in generic anticancer drugs and ...
搜尋條件Meiji Seika Pharma Co.
https://www1.cde.org.tw
搜尋條件Meiji Seika Pharma Co., Ltd. ，搜尋結果清單如下，共搜尋到1筆資料：. No. 1 執行狀態：進行中 試驗藥品名稱/ 成分： Nacubactam / Nacubactam. 試驗計畫標題 ...
Meiji Seika Pharma Co.
https://www.jpma.or.jp
Meiji Seika Pharma Co., Ltd. Address. 2-4-16 Kyobashi, Chuo-ku, Tokyo 104-8002. Contact. Phone：+81-3-3273-6030. FAX：+81-3-3281-7046. Homepage.
Meiji Seika Pharma Co.
https://www.amrindustryallianc
Meiji Seika Pharma Co., Ltd., Japan. 4-16 Kyobashi 2-chome, Chuo-ku, Tokyo 104-8002, Japan. Website. stay informed. Subscribe to receive our updates.
The World's First Approved Vaccine Applying Self
https://www.meiji-seika-pharma
Meiji Seika Pharma obtained exclusive rights to distribute Kostaive™ (ARCT-154)_ in Japan from CSL Seqirus on April 11, 2023, and is ...